Cite

    Alison Handley et al.. “Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study.” Clinical and experimental hypertension, vol. 38, 2016, pp. 180–188. http://access.bl.uk/ark:/81055/vdc_100031152182.0x000020